Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms

NCT06302933 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT06302933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Not applicable
Overall status
Unknown status
Start date
May 2, 2024
Completion date
August 30, 2025
Enrollment
451 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections